Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Loading...
Loading...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--

Fluidigm Corporation FLDM today announced that President and Chief Executive Officer Gajus Worthington will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, on Thursday, January 16, 2014, at 8:30 a.m. (PST).

Audio of Fluidigm's presentation will be webcast at:
http://jpmorgan.metameetings.com/confbook/healthcare14/directlink?ticker=FLDM

The webcast will be archived for 90 days following the live presentation.

About Fluidigm

Fluidigm FLDM develops, manufactures, and markets microfluidic systems to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Fluidigm's proprietary microfluidic systems consist of instruments and consumables, including 18 different commercial integrated fluidic circuits for nucleic acid analysis, and three families of assay chemistries. These systems are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm products are provided: For Research Use Only. Not for use in diagnostic procedures.

For more information, please visit www.fluidigm.com.

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.

Fluidigm Corporation
Un Kwon-Casado, CFA, 650-266-6035
VP, Corporate Development
un.kwon-casado@fluidigm.com

Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...